منابع مشابه
Bundled Payment and Care of Acute Stroke: What Does it Take to Make it Work?
W ith nearly 800 000 strokes occurring a year, stroke remains the leading cause of disability and the fourth most common cause of death in the United States. 1 Stroke also imposes an enormous economic burden, including long-term care costs and productivity losses. Total direct medical stroke-related costs to US economy are projected to triple from $71.6 billion in 2012 to $184.1 billion in 2030...
متن کاملWhat does it take to make the perfect clot?
The coagulation process has been conceptualized as being primarily dependent on adequate levels of the coagulation proteins. This concept was based on the clear relationship between the bleeding tendency and factor levels in hemophilia. The field is now evolving toward conceptualizing coagulation as being actively regulated by the specialized cellular components of the process. Rather than conc...
متن کاملWhat does it cost to live with HIV?
from 80% to 100% of a student’s time for up to 2 years of clinical research, during which the study of pain management and breathlessness will be high priorities. The grants program aims to use evidence-based research on medications used to treat these symptoms to develop equitable, cost-effective access to drugs across the country. Faculty scholarships lasting up to 2 years will be open to a w...
متن کاملWhat does it cost the patient to see the doctor?
Against a background of increasing demands on limited resources, there will be an emphasis on undertaking studies that relate benefits of an intervention to the costs that are incurred in their production. Patient costs are an important, but often overlooked, part of an economic exercise and include transport costs, loss of employment, and loss of leisure time. This paper highlights the theoret...
متن کاملSurgical debulking of ovarian cancer: what difference does it make?
Three-quarters of women who are newly diagnosed with invasive epithelial ovarian cancer present with stage III to IV disease. Recent data on the efficacy of neoadjuvant chemotherapy have served to challenge the conventional dogma that the preferred initial treatment is surgical debulking. Most of these patients will achieve remission regardless of initial treatment, but 80% to 90% of patients w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Review of Network Economics
سال: 2003
ISSN: 1446-9022,2194-5993
DOI: 10.2202/1446-9022.1024